Tender detail
Conclusion of a non-exclusive rebate agreement for medicinal products containing varenicline
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for medicinal products containing varenicline for the period 01/08/2026 to 31/07/2028, with an option to extend once by 12 months. DAK-Gesundheit intends to conclude rebate agreements with as many interested pharmaceutical companies as possible. The bidder should note that the agreement will end automatically when an exclusive agreement enters into force.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.